Factors Predicting the Duration of Effectiveness of Viscosupplementation in Knee Arthosis
Launched by HOPITAL NORD FRANCHE-COMTE · Jul 26, 2021
Trial Information
Current as of June 17, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All adult outpatients, of both sexes, regardless of age, with a doctor-accepted diagnosis of knee OA and who have been treated with SV within the past 3 years
- Exclusion Criteria:
- • Patients who have not been treated with SV in the past 3 years.
- • Patients who have been treated with VS for an indication other than osteoarthritis of the knee.
- • Patients in whom the assessment could not be performed reliably
About Hopital Nord Franche Comte
Hospital Nord Franche-Comté is a leading healthcare institution located in the Franche-Comté region of France, dedicated to providing high-quality medical care and advancing clinical research. With a strong emphasis on innovation and patient-centered services, the hospital collaborates with various stakeholders to conduct clinical trials that aim to enhance treatment options and improve health outcomes. Its multidisciplinary team of healthcare professionals and researchers is committed to adhering to the highest ethical standards and regulatory guidelines, ensuring the integrity and reliability of trial results while prioritizing patient safety and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Trévenans, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials